A Study of Minirin Melt in Patients With Nocturia

N/ACompletedNCT01222598

Ferring Pharmaceuticals588 enrolled

Overview

This is a confirmation of safety profile for Minirin Melt in clinical practice.

Study Type

OBSERVATIONAL

Enrollment

588

Conditions

Nocturia

Eligibility

Sex: ALLMin age: 18 YearsMax age: 64 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients suffering from Nocturia Exclusion Criteria: * habitual or psychogenic polydipsia * known or suspected cardiac insufficiency and other conditions requiring treatment with diuretics * moderate and severe renal insufficiency * know hyponatremia * syndrome of inappropriate ADH secretion

Locations (37)

Outcomes

Primary Outcomes

Number of participants with adverse events

Time frame: 12 months

Secondary Outcomes

Number of participants with nocturnal voiding

Time frame: 12 months

Number of participants with adverse events

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Private Ambulance

Blansko, Czechia

Private Ambulance

Brno, Czechia

Trauma Hospital in Brno

Brno, Czechia

Urocentrum

Brno, Czechia

Uromeda, s.r.o.

Brno, Czechia

Private Ambulance

Brno-Zábrdovice, Czechia

Private Ambulance

Bystřice pod Hostýnem, Czechia

Hospital Dečín

Děčín, Czechia

University Hospital Hradec Králové

Hradec Králové, Czechia

Hospital Jablonec nad Nisou

Jablonec nad Nisou, Czechia

...and 27 more locations